How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study

BACKGROUND: Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most severely hypoxemic, acute respiratory distress syndrome (ARDS) patients. However, the recommended dosage as well as the necessity of monitoring the neuromuscular block is unknown. We aimed to evaluat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Intensive Care
Main Authors: Hraiech, Sami, Forel, Jean-Marie, Guervilly, Christophe, Rambaud, Romain, Lehingue, Samuel, Adda, Mélanie, Sylla, Pierre, Valera, Sabine, Carvelli, Julien, Gainnier, Marc, Papazian, Laurent, Bourenne, Jérémy
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540745/
https://ncbi.nlm.nih.gov/pubmed/28770545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13613-017-0305-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados